MNKD: MannKind Corp. Operating Profitability

Symbol and logo of brand mannkindcorp.com (MNKD)

Operating margins for MannKind Corporation (MNKD) on this GURU.Markets chart show a metric value of -2.00. This trend is driven by a unique insulin delivery method, where patent protection and the demand for consumables guarantee stable sales. Payments from United Therapeutics and the development of the pulmonary portfolio are stimulating the rise in share prices. A steady cash flow from partnerships creates a solid financial foundation for the business.

MNKD: MannKind Profitability of Operations 07/04/2022 - 11/20/2026

Analytical breakdowns for MannKind (MNKD)

Fundamental company valuation:Afrezza, MNKD
Finished products of mannkindcorp.com

Stable capacity utilization at MannKind Corporation (MNKD) inhalation system plants forms the basis for analyzing operational efficiency. This metric calculates the profit share from the core business before interest and taxes. The trend in the final operating margin reflects the impact of packaging line automation on cost reduction. Investors should interpret the growth of this indicator as an optimization of internal processes. The asset belongs to the high-tech pharmaceutical sector.

Analysis of competing companies

Operating Profitability haleon.com|Operating Profitability KVUE|Operating Profitability Verona Pharma (VRNA)|Jyong Biotech (MENS) - Operating Profitability Margin|Operating Margin LGND (Ligand Pharma)|Amneal Pharmaceuticals Inc - Operating Profitability|PRGO - Operating Profitability|Alvotech Corp (ALVO) - Operating Sales Margin|LQDA: Operating Margin|Operating Return on Sales glpg.com (GLPG)|Operating Profitability ANI Pharmaceuticals Inc|AMPH: Operating Profit Rate|Operating Profitability pacira.com (PCRX)|Operating Margin ARS Pharma (SPRY)|Theravance Biopharma - Operating Sales Margin|Operating Profit Ratio AQST (Aquestive Therapeutics)|SCPH: Operating Sales Margin|Operating Return on Sales Tectonic Therapeutic|TNXP: Operating Margin|SXT China (SXTC) - Operating Margin|Operating Profitability eupraxiapharma.com|BioHarvest Sciences (BHST) - Profitability of Operations|Operating Profitability Invizyne (EXOZ)|ORMP - Operating Return on Sales|Operating Margin ENTX (Entera Bio)|Operating Profitability Margin MindWalk Therapeutics|ABVC: Operating Sales Margin|CPIX - Operating Margin|QNTM (Quantum BioPharma) - Operating Sales Margin|Operating Profit Margin FGEN (FibroGen)|TELO (Telomir Pharmaceuticals Corp) - Operating Margin|Operating Margin ranitherapeutics.com|Operating Profitability Synergy CHC Corp. (SNYR)|Rallybio Corp - Return on Sales by Operating Profit|lexariabioscience.com - Operating Sales Margin|Operating Margin Pulmatrix Inc PULM|Pheton Holdings - Operating Margin|Operating Profit Margin APM|Lyra Therapeutics, Inc. (LYRA) - Operating Profitability|Operating Return on Sales Impact BioMedical, Inc. (IBO)|Operating Profitability TNF Pharma|YCBD: Operating Profit Rate|Operating Margin PRFX|CYTO - Operating Return on Sales|Operating Profitability Lipella LIPO|Operating Profit Ratio OPTN (OptiNose, Inc.)|PIRS - Operating Profitability|Procaps (PROC) - Operating Sales Margin|PTPI: Operating Margin|Qilian International (QLI) - Operating Margin|Operating Profitability Acelyrin, Inc.|Operating Margin TFF Pharmaceuticals, Inc.